2
results found
Background: Among F8 mutation types, main determinants of inhibitor development after replacement therapy in Hemophilia A, nonsense mutations display wide variation in the associated risk. Molecular m...
F8 PTCs
Hemophilia A
translational readthrough
inhibitory antibody
peptide MHCII affinity
personalized medicine
The rapid advancement of Artificial Intelligence of Things (AIoT) in smart pharmaceutics promises personalized and adaptive drug delivery systems with real-time monitoring and precise dosing. However,...
Machine unlearning
AIoT
smart pharmaceutics
privacy-preserving drug delivery
cybersecurity
digital twins
personalized medicine
SinoXiv